Back to Aberdeen Group plc Aberdeen Group plc

LENZLENZ
5 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in LENZ THERAPEUTICS INC

Yes. Aberdeen Group holds 1,547,883 shares of LENZ (Lenz Therapeutics), worth $8.8M, as of its Q2 2026 13F filing. It increased the position by 391,722 shares (+33.9%) from Q1 2026. Aberdeen Group has held LENZ since Q2 2025, across 5 quarterly 13F filings.

Current Value

$8.8M

Current Shares

1.5M

Total Value Change

+$6.6M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+33.9%
$8.8M0.0%$5.68
35
2026-Q1
Increased
1.2M
+136.2%
$10.6M0.0%$13.15
45
2025-Q4
Increased
489,432
+274.4%
$7.8M0.0%$16.12
44
2025-Q3
Increased
130,726
+76.0%
$6.1M0.0%$44.89
41
2025-Q2
New
74,286
-
$2.2M0.0%$30.18
36

Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used